Cargando…
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
BACKGROUND: Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte homeostasis and immunological tolerance due primarily to genetic defects in Fas (CD95/APO-1; TNFRSF6), a cell surface receptor that regulates apoptosis and its signaling apparatus. METHODS: Fas ligand gene mutatio...
Autores principales: | Bi, Lilia L, Pan, George, Atkinson, T Prescott, Zheng, Lixin, Dale, Janet K, Makris, Christopher, Reddy, Vishnu, McDonald, Jay M, Siegel, Richard M, Puck, Jennifer M, Lenardo, Michael J, Straus, Stephen E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931585/ https://www.ncbi.nlm.nih.gov/pubmed/17605793 http://dx.doi.org/10.1186/1471-2350-8-41 |
Ejemplares similares
-
Mutations in the Fas gene found in Spanish ALPS (autoimmune lymphoproliferative syndrome) patients
por: Martínez-Martínez, L, et al.
Publicado: (2010) -
Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome
por: Cerutti, Elisa, et al.
Publicado: (2007) -
Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?
por: Palmisani, Elena, et al.
Publicado: (2023) -
HIV-1 Directly Kills CD4(+) T Cells by a Fas-independent Mechanism
por: Gandhi, Rajesh T., et al.
Publicado: (1998) -
Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)
por: Lisco, Andrea, et al.
Publicado: (2019)